[](//www.DrugPatentWatch.com/p/preview/generic-api/sofosbuvir?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog)
Sofosbuvir is the generic ingredient in three branded drugs marketed by Gilead Sciences Inc and is included in four NDAs. There are twenty-six patents protecting this compound.
Drug patent litigation for SOFOSBUVIR.
One supplier is listed for this compound. There is one tentative approval for this compound.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
